Skip to main content

Value of QC Testing in ATMP

When Rapid Time to Results Matters

OVERVIEW

In this webinar, you’ll learn more about:

  • Improving the time to result of QC testing with rapid and automated solutions to reduce patient to patient time
  • Advance safety testing of ATMP from raw materials to product release
  • Bringing flow cytometry analysis to point-of-need

 

SPEAKERS

Felix Montero Julian
Director, Scientific Affairs
bioMérieux

Rey Mali
Vice President, Sales and Marketing
Accellix

ACCESS TO THE WEBINAR REPLAY →

  

Related Resources

Collaboration in ATMP Development

Collaboration has been a huge part of the COVID-19 pandemic response, but it is also hugely important in the development of various other therapeutics. In the second episode in our advanced therapy medicinal products (ATMPs) series Jérôme Larghero, Director of the Department of Biotherapies and the MEARY Center for Cell and Gene Therapy in the Hôpital Saint-Louis, AP-HP, and Julien Textoris, Vice President of Global Medical Affairs, Immunoassays and host response at bioMérieux, discuss the importance of collaboration between academia and industry in the development of ATMPs.
Learn More

Future of ATMPS

Is the future of cell and gene therapy autologous or allogeneic? Which solid tumour may receive the first cell therapy treatment? How will the use of ATMPs in cancer care change our healthcare structures in years to come? Discover all this and more in this podcast with bioMérieux.
Learn More

Pharma Quality Control

We help the pharmaceutical industry ensure product quality through our comprehensive portfolio of efficient solutions for microbial quality control. Our complete line of diagnostic solutions provides simplified workflows for routine testing, rapid results, and ensures patient safety.
Learn More